Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Megan H, Jagosky"'
Autor:
Megan H. Jagosky, Colin J. Anderson, James T. Symanowski, Nury M. Steuerwald, Carol J. Farhangfar, Emily A. Baldrige, Jennifer H. Benbow, Michael B. Livingston, Joshua C. Patt, Will A. Ahrens, Jeffrey S. Kneisl, Edward S. Kim
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7029-7038 (2023)
Abstract Purpose Patients with unresectable dedifferentiated liposarcoma (DDLPS) have poor overall outcomes. Few genomic alterations have been identified with limited therapeutic options. Experimental Design Patients treated at Levine Cancer Institut
Externí odkaz:
https://doaj.org/article/7e061913e58d4d3093d3ab4b289a48b5
Autor:
Megan H, Jagosky, Colin J, Anderson, James T, Symanowski, Nury M, Steuerwald, Carol J, Farhangfar, Emily A, Baldrige, Jennifer H, Benbow, Michael B, Livingston, Joshua C, Patt, Will A, Ahrens, Jeffrey S, Kneisl, Edward S, Kim
Publikováno v:
Cancer Medicine. 12:7029-7038
Patients with unresectable dedifferentiated liposarcoma (DDLPS) have poor overall outcomes. Few genomic alterations have been identified with limited therapeutic options.Patients treated at Levine Cancer Institute with DDLPS were identified. Next gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987f34a322de0cc7dffc986d5ebe7bf4
https://doi.org/10.1002/cam4.5502
https://doi.org/10.1002/cam4.5502
Autor:
Edward S. Kim, Jeffrey S. Kneisl, Joshua C. Patt, Colin J. Anderson, Nury M. Steuerwald, James T. Symanowski, Xhevahire Begic, Emily A. Baldrige, Deirdre M. Maxwell, David M. Foureau, Carol J. Farhangfar, Jennifer H. Benbow, William A. Ahrens, Myra M. Robinson, Megan H. Jagosky, Michael B. Livingston
Treatment Emergent Adverse Events Attributed to Pembrolizumab, Any Grade.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf832be93579c2f32e46091b3577a41b
https://doi.org/10.1158/1078-0432.22483110.v1
https://doi.org/10.1158/1078-0432.22483110.v1
Autor:
Edward S. Kim, Jeffrey S. Kneisl, Joshua C. Patt, Colin J. Anderson, Nury M. Steuerwald, James T. Symanowski, Xhevahire Begic, Emily A. Baldrige, Deirdre M. Maxwell, David M. Foureau, Carol J. Farhangfar, Jennifer H. Benbow, William A. Ahrens, Myra M. Robinson, Megan H. Jagosky, Michael B. Livingston
All Treatment Emergent Adverse Events Regardless of Causality, Any Grade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7850331292f3a8df2d0b89871ed91528
https://doi.org/10.1158/1078-0432.22483116.v1
https://doi.org/10.1158/1078-0432.22483116.v1
Autor:
Edward S. Kim, Jeffrey S. Kneisl, Joshua C. Patt, Colin J. Anderson, Nury M. Steuerwald, James T. Symanowski, Xhevahire Begic, Emily A. Baldrige, Deirdre M. Maxwell, David M. Foureau, Carol J. Farhangfar, Jennifer H. Benbow, William A. Ahrens, Myra M. Robinson, Megan H. Jagosky, Michael B. Livingston
Purpose:Doxorubicin is standard therapy for advanced soft-tissue sarcoma (STS) with minimal improvement in efficacy and increased toxicity with addition of other cytotoxic agents. Pembrolizumab monotherapy has demonstrated modest activity and tolerab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20971f5acf9784dd02c761e4e33482dc
https://doi.org/10.1158/1078-0432.c.6531075.v1
https://doi.org/10.1158/1078-0432.c.6531075.v1
Autor:
Edward S. Kim, Jeffrey S. Kneisl, Joshua C. Patt, Colin J. Anderson, Nury M. Steuerwald, James T. Symanowski, Xhevahire Begic, Emily A. Baldrige, Deirdre M. Maxwell, David M. Foureau, Carol J. Farhangfar, Jennifer H. Benbow, William A. Ahrens, Myra M. Robinson, Megan H. Jagosky, Michael B. Livingston
Study inclusion and exclusion criteria.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daecebe2176fecba4b25c38c536c6195
https://doi.org/10.1158/1078-0432.22483107
https://doi.org/10.1158/1078-0432.22483107
Autor:
Edward S. Kim, Jeffrey S. Kneisl, Joshua C. Patt, Colin J. Anderson, Nury M. Steuerwald, James T. Symanowski, Xhevahire Begic, Emily A. Baldrige, Deirdre M. Maxwell, David M. Foureau, Carol J. Farhangfar, Jennifer H. Benbow, William A. Ahrens, Myra M. Robinson, Megan H. Jagosky, Michael B. Livingston
Treatment Emergent Adverse Events Attributed to Either Doxorubicin, Pembrolizumab, or Both, Any Grade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251f8b19db42a7cbd1ed256ffe206398
https://doi.org/10.1158/1078-0432.22483113.v1
https://doi.org/10.1158/1078-0432.22483113.v1
Autor:
Malcolm H. Squires, Cecilia G. Ethun, Erin E. Donahue, Jennifer H. Benbow, Colin J. Anderson, Megan H. Jagosky, Munsa Manandhar, Joshua C. Patt, Jeffrey S. Kneisl, Jonathan C. Salo, Joshua S. Hill, William Ahrens, Roshan S. Prabhu, Michael B. Livingston, Nicole L. Gower, McKenzie Needham, Sally J. Trufan, Ryan C. Fields, Bradley A. Krasnick, Meena Bedi, Konstantinos Votanopoulos, Konstantinos Chouliaras, Valerie Grignol, Kevin K. Roggin, Jennifer Tseng, George Poultsides, Thuy B. Tran, Kenneth Cardona, J. Harrison Howard
Publikováno v:
Annals of Surgical Oncology. 29:3304-3305
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5559b35deb095137334f986800b2a2b0
https://doi.org/10.1245/s10434-021-11263-9
https://doi.org/10.1245/s10434-021-11263-9
Autor:
Malcolm Hart Squires, Cecilia G. Ethun, Erin E. Donahue, Jennifer H. Benbow, Colin J. Anderson, Megan H. Jagosky, Munsa Manandhar, Joshua C. Patt, Jeffrey S. Kneisl, Jonathan C. Salo, Joshua S. Hill, William Ahrens, Roshan S. Prabhu, Michael B. Livingston, Nicole L. Gower, McKenzie Needham, Sally J. Trufan, Ryan C. Fields, Bradley A. Krasnick, Meena Bedi, Konstantinos Votanopoulos, Konstantinos Chouliaras, Valerie Grignol, Kevin K. Roggin, Jennifer Tseng, George Poultsides, Thuy B. Tran, Kenneth Cardona, J. Harrison Howard
Publikováno v:
Annals of surgical oncology. 29(5)
Prognostic nomograms for patients with resected extremity soft tissue sarcoma (STS) include the Sarculator and Memorial Sloan Kettering (MSKCC) nomograms. We sought to validate these two nomograms within a large, modern, multi-institutional cohort of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077c2581fb2899ba024a8219cfdc28b0
https://pubmed.ncbi.nlm.nih.gov/35015183
https://pubmed.ncbi.nlm.nih.gov/35015183
Autor:
Kunal C, Kadakia, Sally J, Trufan, Megan H, Jagosky, William M, Worrilow, Bradley W, Harrison, Katherine L, Broyhill, Jimmy J, Hwang, Laura W, Musselwhite, Aynur, Aktas, Declan, Walsh, Mohamed E, Salem
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(7)
Little is known about the use of palliative and hospice care and their impact on healthcare utilization near the end of life (EOL) in early-onset pancreatic cancer (EOPC).Patients with EOPC (≤ 50 years) were identified using the institutional tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6390a6b2a2c940b697bd8a94616c2a1b
https://pubmed.ncbi.nlm.nih.gov/33170401
https://pubmed.ncbi.nlm.nih.gov/33170401